Targeted therapies

New standard for relapsed ALL

Article metrics

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Kantarjian, H. M. et al. Blinatumomab versus chemotherapy for advanced acute lymphoma leukemia. N. Engl. J. Med. 376, 836–847 (2017)

Download references

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading